IGCLBSEIndogulf Cropsciences LtdHighNeutral
Announced Thu, 28 May · 19:33 IST

Press Release -Financial Results for the Year ended March 31, 2026

Investor Communications View source PDF

IGCL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-6.2%1-day move
₹62.90
prior close
₹64.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-1.6-1.6-3.0-6.6-6.2-7.9-7.8-9.3-9.9-5.4-2.2-4.3
Up moveDown movePending
AI summary

Indogulf Cropsciences reported FY26 revenue of ₹7,046 million, up 19% YoY from ₹5,904 million, while PAT grew 27% to ₹400 million. EBITDA rose 15% to ₹740 million, but EBITDA margin contracted by 40 basis points to 10.4% from 10.8% in FY25, indicating margin pressure despite strong top-line growth. Q4 FY26 showed similar trends with 19% revenue growth to ₹1,508 million and PAT growth of 19% to ₹116 million, though Q4 EBITDA margin fell 300 bps to 14%. Management cited distribution expansion, new export markets (Venezuela, Taiwan, Sudan), and a growing biologicals portfolio as key growth drivers. The company highlighted capacity utilization improvements and expansion at the Barwasni facility, with a distribution network of 7,000+ distributors and 192 institutional partners.

Likely market impact

Revenue and profit growth are strong, but the sustained EBITDA margin compression (both quarterly and full-year) signals underlying cost or raw material pressures, which could weigh on near-term sentiment despite the solid PAT growth.